Lacidipine: Difference between revisions
m (Protected "Lacidipine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 24: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Lacidipine''' (tradenames '''Lacipil''', '''Motens''') is a [[calcium channel blocker]]. It is available as tablets containing 2 or 4 mg. | '''Lacidipine''' (tradenames '''Lacipil''', '''Motens''') is a [[calcium channel blocker]]. It is available as tablets containing 2 or 4 mg. | ||
==References== | |||
{{reflist|2}} | |||
== External links == | == External links == | ||
| Line 36: | Line 41: | ||
{{Calcium channel blockers}} | {{Calcium channel blockers}} | ||
[[Category: | [[Category: Calcium channel blockers]] | ||
[[Category:Drugs]] | [[Category: Cardiovascular Drugs]] | ||
[[Category: Drug]] | |||
Latest revision as of 20:14, 23 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C26H33NO6 |
| Molar mass | 455.543 g/mol |
|
WikiDoc Resources for Lacidipine |
|
Articles |
|---|
|
Most recent articles on Lacidipine |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Lacidipine at Clinical Trials.gov Clinical Trials on Lacidipine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Lacidipine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Lacidipine Discussion groups on Lacidipine Patient Handouts on Lacidipine Directions to Hospitals Treating Lacidipine Risk calculators and risk factors for Lacidipine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Lacidipine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Lacidipine (tradenames Lacipil, Motens) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.
References
External links
- Motens 2 mg Summary of Product Characteristics
- Motens 4 mg Summary of Product Characteristics
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Calcium channel blockers
- Cardiovascular Drugs
- Drug